Agoracom Blog Home

Author Archive

GGX Gold Update on Gold Drop Drilling $GGX.ca $XIM.ca $K.ca $GOM.ca

Posted by AGORACOM at 9:33 AM on Wednesday, July 24th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564602/hub/ggx_large.png
  • Drilling at the C.O.D. North vein – 421m has been drilled in 7 holes
  • 1,965m drilled in 32 holes on the main COD vein – Assays Due
  • Drill testing “Anomaly” at depths between 500 and 800 metres
  • The anomaly is interpreted as a pipe-like structure measuring 1834 by 1377m

VANCOUVER, BC / ACCESSWIRE / July 24, 2019 / GGX Gold Corp. (TSX-v: GGX), (OTCQB: GGXXF), (FRA: 3SR2) (the “Company” or “GGX”) provides the following update on its exploration activities at its Gold Drop property in the Greenwood Mining Camp.

Drilling resumed as of July 16 at the C.O.D. North vein. As of July 22, a total of 421 metres has been drilled in 7 holes on the COD North, in addition to the total of 1,965 metres drilled in 32 holes on the main COD vein. An initial batch of samples was submitted for analyses in late June, but assays have not yet been received.

Preparations are also underway to drill a relatively deep hole on a geophysical anomaly (refer to news release dated July 4). Drill rods and bits have been purchased and a night shift drill crew has been arranged. The drill site has been selected and verified by a representative for Earth Science Services Corporation of Oshawa, Ontario (ESSCO). The initial hole is planned to be drilled to test the target zone at depths between 500 and 800 metres. The anomaly is interpreted as a pipe-like structure that measures 1834 by 1377 metres.

The Company also announces that it has repriced the flow through portion of its private placement originally announced on June 18, 2019. The non brokered private placement will now be an offering of up to 4,000,000 flow through units at a price of Cdn$0.25 per unit for gross proceeds of $1,000,000. Each flow-through unit will comprise one common share (which is a flow-through share for Canadian income tax purposes) and one-half share purchase warrant. Each whole flow-through warrant will entitle the holder to purchase one additional common share which is not a flow-through share at the price of $0.35 for 18 months after closing. The term of the warrants may be accelerated in the event that the issuer’s shares trade at or above a price of $0.40 cents per share for a period of 10 consecutive days. In such case of accelerated warrants, the issuer may give notice, in writing or by way of news release, to the subscribers that the warrants will expire 20 days from the date of providing such notice. The proceeds of the private placement will be used for continued exploration work including diamond drilling and trenching at the Company’s Gold Drop property near Greenwood in Southern British Columbia.

The terms of the non-flow through placement remain as announced on June 18, 2019.

A finder’s fee may be paid to eligible finders in accordance to the TSX-V policies. All securities issued pursuant to the offering will be subject to a hold period of four months and one day from the date of closing. The offerings and payment of finders’ fees are both subject to approval by the TSX-V.

David Martin, P.Geo., a Qualified Person as defined by National Instrument 43-101 and consultant to the Company, approved the technical information in this release.

On Behalf of the Board of Directors
George Sookochoff, President,
604-488-3900
[email protected]

Investor Relations:
Mr. Jack Singh,
604-488-3900,
[email protected]

Applied BioSciences $APPB Announces Two Consecutive Quarters Posting Record Revenues for FY Ended March 2019 $CGRW $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca

Posted by AGORACOM at 8:24 AM on Wednesday, July 24th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
  • FY 2019 revenue of $707,062; a 258% increase from the previous fiscal year with Q4 revenue for the Company of $234,553, representing a 1202% increase from Q4 FY 2018;
  • Launched multiple new products and expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and Shot
  • Appointed Raymond W. Urbanski MD, PhD as Director and CEO;
    Added 3 PhDs and 5 scientists to its operational team;
    Launched the first Organic Human Quality Pet Treats under the HerbalPet bran

Los Angeles, California–(Newsfile Corp. – July 24, 2019) – Applied BioSciences Corp. (OTCQB: APPB), a vertically integrated company focused on the development of science-driven cannabinoid biopharmaceuticals and the production of high-quality CBD products, as well as testing and analytics, and pet health industries, today announced that it has achieved a record revenue quarter with multiple milestones for the fiscal year ended March 31, 2019. The Company has continued to make strategic investments in select brands and companies believed to be innovators in the consumer space. The investment remains on the balance sheet under “Equity Investments,” however the Company has begun a strategic review of options for the remaining equity stake.

Q4 FY 2019 Financial and Operational Highlights

  • FY 2019 revenue of $707,062; a 258% increase from the previous fiscal year with Q4 revenue for the Company of $234,553, representing a 1202% increase from Q4 FY 2018;
  • Launched multiple new products and expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and Shot;
  • Started initial pharmacokinetic safety study with a leading firm in the veterinary space;
  • Commenced discussions regarding proposed scientific trials with two leading Universities specializing in Veterinary Medicine; and
  • Announced the acquisition of Trace Analytics with over 65 years of combined experience in the global testing market for Cannabis and Hemp.

“Applied BioSciences’ results in the fourth quarter mark another record revenue quarter and solid revenue acceleration in our core products businesses. This has led to a historic year in a dynamic and rapidly evolving and growing space. We look forward to providing a corporate update and 2019 business outlook to the investor community on our strategy, milestones and continued progress in the near term,” stated Dr. Raymond W. Urbanski, CEO of Applied BioSciences.

Subsequent to Q4 2019

  • Appointed Raymond W. Urbanski MD, PhD as Director and CEO;
  • Added 3 PhDs and 5 scientists to its operational team;
  • Launched the first Organic Human Quality Pet Treats under the HerbalPet brand; and
  • Appointed Martin Schroeder to the Scientific Advisory Board and as President of Applied BioPharma. Mr. Schroeder has over 30 years of experience in the pharmaceutical and biotech industries and has helped many biotech and pharmaceutical companies conduct search and evaluation of compounds and molecules.

“Applied BioSciences continues to be at the forefront of the evolving consumer and testing market, using organically grown plants, without pesticides or herbicides as our main ingredient. As the Company, continues to expand our product lines it is important to know that our products have been thoroughly tested by trusted labs in the industry for chemicals, pesticides and any harmful materials. All our products are tested to ensure high-caliber and quality as well as overall safety. We will now be able to test our products in an expedited fashion as well as from third-party labs and continue to provide the highest standard of testing results and safety protocols on all our products,” commented JJ Southard, Vice President of Applied BioSciences Corp.

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and media industries.

About Trace Analytics Inc.

Trace Analytics Inc. is a leading cannabis and hemp science and technology company with significant footprints in lab testing, research and development and licensing. Trace Analytics was started by a group of scientists who specialized in analytical chemistry, genetics and molecular biology. The focus of the team is to ensure compliance with public safety standards and end user safety. Trace Analytics is in the process of expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt “best practices” in cannabis and hemp testing, the company also provides expert consulting services to legislators and regulators in many countries, states and municipalities around the world. For more information, please visit: http://traceanalytics.com

Contact
Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com / www.traceanalytics.com

Brands:
www.remedishop.com
www.herbalpet.com
www.canagel.com

Follow us:
Facebook @remedicbd & @HerbalPetMeds
Instagram @remedishop & @herbal_pet
Twitter @remedishop & @herbal_pet

ZEN Graphene Solutions: EV Sales in Europe Exploding $ZEN.ca $LLG.ca $FMS.ca $NGC.ca $CVE.ca $DNI.ca

Posted by AGORACOM at 1:00 PM on Tuesday, July 23rd, 2019

SPONSOR: ZEN Graphene Solutions: An emerging advanced materials and graphene development company with a focus on new solutions using pure graphene and other two-dimensional materials. Our competitive advantage relies on the unique qualities of our multi-decade supply of precursor materials in the Albany Graphite Deposit. Independent labs in Japan, UK, Israel, USA and Canada confirm this. Click here for more information

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564424/hub/Zen_logo.jpg
ZEN – TSX:V
  • The number of electric car models on the European market is set to more than triple in the next three years
  • European Union will jump from around 60 models available at end-2018 to a total of 214 battery electric (BEV), plug-in hybrid (PHEV), and fuel cell (FCEV) models in 2021
  • Production of EVs in Europe is set to surge six-fold between 2019 and 2025, reaching more than 4 million cars and vans

The next two years are likely to be the tipping point for electric vehicles (EVs) going mainstream in Europe, as the number of electric car models on the European market is set to more than triple in the next three years, Transport & Environment (T&E), Europe’s leading clean transport campaign group, says in a new analysis

According to T&E, which analyzed the upcoming offerings using data from authoritative industry source IHS Markit, the number of EV models made across the European Union (EU) will jump from around 60 models available at end-2018 to a total of 214 battery electric (BEV), plug-in hybrid (PHEV), and fuel cell (FCEV) models in 2021, and further up to 333 models in 2025.

“Until recently, the EV market was limited to a niche of early adopters but tomorrow’s landscape will be very different as EVs enter a new phase and near the mass market,” the report from T&E says.

Based on IHS Markit’s light vehicle production forecast data and in-house T&E analysis, the production of EVs in Europe is set to surge six-fold between 2019 and 2025, reaching more than 4 million cars and vans. This production volume would account more than a fifth of the EU car production volumes.

EV manufacturing will be replacing diesel-fueled car making across Europe, with the largest production sites in western Europe—Germany, France, Spain, and Italy, T&E’s analysis shows. In central and eastern Europe, Slovakia, the Czech Republic, and Hungary are also expected to be significant EV production centers.

EV production volumes forecasts for the UK are currently highly uncertain because electric car manufacturing growth could easily be reversed in a no-deal Brexit scenario, according to the analysis.  

All major European carmakers, including Germany’s Volkswagen, BMW, and Daimler, France’s PSA, and the Renault-Nissan-Mitsubishi alliance are expected to roll out a number of EVs in Europe. Fiat Chrysler, Ford, and Tesla will also offer new models in Europe by 2025, the report showed. Related: Gloomy Investor Sentiment Darkens Outlook For Oil & Gas

“Thanks to the EU car CO2 standards, Europe is about to see a wave of new, longer range, and more affordable electric cars hit the market. That is good news but the job is not yet done. We need governments to help roll out EV charging at home and at work, and we need changes to car taxation to make electric cars even more attractive than polluting diesels, petrols or poor plug-in hybrid vehicles,” Lucien Mathieu, transport and e-mobility analyst at T&E, said.

“This is a pivotal moment for Europe’s automotive industry,” Mathieu added, noting that carmakers are investing a combined US$163 billion (145 billion euro) in electrification, and “battery making is finally coming to Europe.”

“We need to send a clear signal to industry that there is no way back, and agree a phase-out of petrol and diesel car sales in cities, at national and EU level. The age of the combustion engine is coming to an end,” Mathieu concluded.  

Sales of EVs in Europe are growing, and the undisputed leader in terms of market penetration is Norway, which is not a member of the EU.

For the first time ever, EV sales in Norway in March outstripped sales of gasoline and diesel cars combined, confirming the Nordic country’s undisputed global leadership in EV market share. The nearly 60-percent record EV market share in March was driven by two key factors—Norway’s consistent government policies in incentivizing purchases of zero-emission cars and a record number of Tesla Model 3 deliveries in March.

Norway may have a population of just 5.3 million people, but it is an important market for all EV makers, especially for Tesla. This importance is also recognized by Elon Musk who retweeted with heart emoticons Norway’s sales numbers for March.  

In the United States, the absolute number of EV sales is still tiny compared to the overall market. Yet new registrations of fully EVs in the United States hit a record 208,000 cars in 2018, more than double the new registrations in 2017, IHS Markit said in an analysis earlier this year.

The EV market will grow in the United States and in the world, the analysis says, but adds that one thing is clear: “the internal combustion engine is not going away any time soon, with IHS Markit forecasters anticipating them to continue to dominate the global market until past 2030.”  

SOURCE: By Tsvetana Paraskova for Oilprice.com https://oilprice.com/Alternative-Energy/Renewable-Energy/Electric-Vehicle-Sales-Are-Exploding-In-Europe.html

Great Atlantic Resources $GR.ca – Gold Heats Up And Silver Joins The Race $OM.ca $GGX.ca $GWM.ca $CNX.ca $SIC.ca $MOZ.ca $AGB.ca

Posted by AGORACOM at 11:06 AM on Tuesday, July 23rd, 2019

SPONSOR: Great Atlantic Resources. A Canadian exploration company focused on the discovery and development of mineral assets in the resource-rich and sovereign risk-free realm of Atlantic Canada, one of the number one mining regions of the world. Great Atlantic is currently surging forward building the company utilizing a Project Generation model, with a special focus on the most critical elements on the planet that are prominent in Atlantic Canada, Antimony, Tungsten and Gold. Click Here for More Info

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564603/hub/GREATATLANTIC_LOGO_TESTER-e1480712241913.jpg
GR: TSX-V
  • Next level for gold is $1500
  • Ray Dalio, Billionaire hedge fund manager pro gold
  • Potential interest rate cuts gold positive

Now that gold has broken through the $1,450 an ounce level, a six-high year high, the next big test is $1,500. And as I’ve said before, it can do this in the blink of an eye under the right conditions.

We may end up seeing those conditions emerge sooner rather than later.

Last Thursday, Federal Reserve Bank of New York President John Williams seemed to indicate that a rate cut could be expected later this month, saying that central bankers need to “act quickly” as economic growth cools. Although he later clarified his comment, claiming he was simply citing research and not forecasting central bank action, the price of gold jumped as much as 2 percent on the news before closing above $1,440 for the first time since May 2013.

Investors took some profits last Friday, knocking the price down around 1 percent after gold started to look overbought a day earlier. The metal was up two standard deviations over the past 60 trading days, its highest level since April 2016. I would consider each pullback such as this a buying opportunity, though, because I believe the best is yet to come for the metal.

Gold Price Up Two Standard Deviations

Gold Price Up Two Standard Deviations U.S. Global Investors

Ray Dalio seems to agree. In a lengthy post on LinkedIn—Dalio’s favorite platform for getting the word out—the billionaire hedge fund manager writes that he thinks we’re on the verge of a new economic paradigm shift and that central banks’ accommodative policies, from low rates to quantitative easing (QE), are unsustainable. To hedge against this, Dalio says, “I believe that it would be both risk-reducing and return-enhancing to consider adding gold to one’s portfolio.” Most investors are underweighted in gold, “meaning that if they just wanted to have a better balanced portfolio to reduce risk, they would have more of this sort of asset,” he writes.

A Monster Rally for Juniors

Select junior and micro-cap gold and precious metal miners also posted very strong growth over the past week, mostly on positive drilling results. In a press release dated July 15, Brixton Metals announced encouraging results at its wholly owned Thorn Gold-Copper-Silver Project in British Columbia. Gary Thompson, chairman and CEO of the Vancouver-based explorer and developer, said that Brixton “continues to unlock a mountain of value” at the property, which exhibits even greater mineralization than was previously thought.

Junior Miners Had a Strong Week

Junior Miners Had a Strong Week U.S. Global Investors

As for silver, I’m pleased to see that it’s finally playing “catch up” to gold, its price having hit a 52-week high after an incredible six straight days of gains.

Silver Is Trying to Narrow Its Gap With Gold

Silver Is Trying to Narrow Its Gap With Gold U.S. Global Investors

The Bullish Calls on Gold Continue

With gold having already broken out of its five-year trading range, is the best still yet to come?

I believe it is. And I’m not alone. Read what some analysts and strategists have to say:

Alpine Macro

“The Fed is getting ready to cut interest rates, which should set in motion a multi-year bear market in the dollar,” write analysts at Alpine Macro in a research note dated June 28. A weaker U.S. dollar is one of three “key ingredients” for a bull market, according to Alpine Macro, the other two being a more accommodative Fed and rising geopolitical risks.

“The technical break above $1,400 an ounce is a positive sign,” the firm adds. “New all-time highs for gold should be seen in the coming years.”

World Gold Council (WGC)

“The prospect of lower interest rates should support gold investment demand,” the World Gold Council (WGC) says in its mid-year outlook. “Our research indicates that the gold price was higher in the 12 months following the end of a tightening cycle. Moreover, historical gold returns are more than twice their long-term average during periods of negative real rates—like the one we are likely to see later this year.”

Canadian Imperial Bank of Commerce (CIBC)

“We continue to see no signs of rate hikes on the horizon over the next several years, and historically have seen gold continue on an upward trajectory beyond the last rate cut,” writes CIBC in a note dated July 14.

The bank points out that in two previous gold bull market cycles—in the 1970s and 2000s—negative real rates were the main contributing factor.

“During the last two major periods when real rates stayed below the 2 percent level and actually ticked into negative territory, the gold price moved over 320 percent in the 1970s… and approximately 400 percent from 2004 to peak in 2011.”

For full disclosures pertaining to this post click here.

Applied Biosciences – $APPB CBD Consumer Companies Seeing High Interest, But M&A Future Clouded In Smoke $CGRW $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca

Posted by AGORACOM at 9:07 AM on Tuesday, July 23rd, 2019

SPONSOR: Applied Biosciences Corp. is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, as well as state-of-the-art testing and analytics. As a leading company in the CBD, Pet and Health and Wellness space, the company is currently shipping to the majority of US states as well as to 5 International countries. Click Here for More Info

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
APPB : OTC
  • CBD-derived beauty, personal care and pet brands, among others, have made their way into national retail chains like Walgreens, Sephora and American Eagle Outfitters.
  • Industry experts say regulatory uncertainty and the young age of the category could result in more minority investments than buyouts in the near term.

With fewer restrictions than ever, buyers are increasingly curious about the smoking hot CBD-infused consumer products space, but industry experts say remaining regulatory uncertainty and the young age of the category could result in more minority investments than buyouts in the near term.

The inflection point for bringing CBD, or the non-psychoactive part of the cannabis plant, into the mainstream was the passage of the 2018 US Farm Bill last December, which lifted restrictions on selling hemp-derived products across state lines. Since then, CBD-derived beauty, personal care and pet brands, among others, have made their way into national retail chains like Walgreens, Sephora and American Eagle Outfitters.

CBD oil hemp products, Medicinal cannabis with extract oil in a bottle on a wooden table. Medical cannabis concept

CBD oil hemp products, Medicinal cannabis with extract oil in a bottle on a wooden table. Medical cannabis concept Getty

Michael Lux, a Denver-based Partner at accounting firm Crowe, said he expects strategic minority investments to make up the bulk of CBD’s activity over the next 6-12 months. Although many of the industry’s players are “growing like weeds,” he explained that most are younger than five years old and not ready to explore full exits.

Despite the category’s youth, Lux said interest from consumer packaged goods (CPG) companies has been “very high,” and noted that many of his firm’s CBD-based consumer clients have been approached for strategic investments, as well as research and retail partnerships.

However, one industry banker cautioned that “it will be a bit off” before the market can expect to see acquisitions from traditional CPG groups, particularly for ingestible products like beverages and edibles, since the Food and Drug Administration (FDA) is still working to create a regulatory framework for CBD.

Earlier this week, the FDA announced that it is expediting its effort to create clearer guidelines for CBD, which is believed to have healing property for a range of conditions, including inflammation and anxiety. The department plans to publish a report on its progress by early fall.

In the meantime, companies who operate in the personal care space, with products like CBD-infused topical creams, beauty products and tinctures, are more likely to receive strategic investments, said the banker and a second banker interviewed for this report. Both noted that regulators are more comfortable with non-digestible products, making them a less risky investment.

Canadian cannabis companies, many of which have dual listings on the Canadian and US stock exchanges, are especially likely to invest in US CBD brands in the near term, each of the sources said. They explained that these businesses provide entry into the US market without jeopardizing their US listings, since THC is still federally illegal in the US.

CBD stands for cannabiodil and lacks the psychoactive properties of THC (which stands for tetrahydrocannabinol). Both naturally occur in marijuana/hemp and the farm bill legalized hemp products with only low concentrations of THC.

Seattle-based Lazarus Naturals, which was founded in 2014 and sells CBD-based supplements and personal care products, is one such company. In an April interview with Mergermarket, CEO Sequoia Price-Lazarus said the business has received approaches from publicly-traded Canadian cannabis companies. Though not pursuing a sale, the executive said the company is considering raising up to $20 million in growth capital this year.

Cannabis producer Canopy Growth’s acquisition of London-based natural skincare company This Works in May was more evidence of hemp producers’ interest in the personal care space.

While some financial sponsors, such as Seattle-based Privateer Holdings, were built specifically to invest in CBD and cannabis brands, each of the sources said most US financial sponsors would be barred from investing in the category since most existing funds restrict investments in the space. Lux said he has “heard of a few” sponsors who are interested in raising CBD-friendly funds, but noted that this could take a significant amount of time.

Strategic buyers across a range of industries, including pharmaceuticals, consumer products and food and beverage, are expected to show interest in acquiring CBD brands once FDA regulations become more clear, but in the meantime, activity will be limited to minority investments, particularly from Canada, each of the sources agreed.

“I think people are still trying to figure out where this is going to go,” said Lux. “It’s an industry that didn’t exist 10 years ago and barely existed five years ago, and it sounds cliché, but the sky really is the limit here.”

SOURCE: By Emily Fasold , Forbes

https://www.forbes.com/sites/mergermarket/2019/07/22/cbd-consumer-companies-seeing-high-interest-but-ma-future-clouded-in-smoke/#533e55d25a0f

CLIENT FEATURE: $LMR.ca Lomiko Metals Aims To Develop Graphite Anode Material for EVs $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca $DNI.ca

Posted by AGORACOM at 4:18 PM on Monday, July 22nd, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564363/hub/lomikoLogo300x100_copy.gif
  • Estimates point to 2022 as equilibrium between Electric and Combustible Sales
  • Graphite anode demand is set to increase from 194,160 tonnes in 2017 to 1,080,360 tonnes by 2023 and 1,747,800 tonnes by 2028
  • Automakers are taking action to put millions of electric vehicles on the road
  • Quebec and B.C Governments dedicated to “Green Economy”
https://gallery.mailchimp.com/2fe0087a9b2278d50d87798f3/images/c1dcd6f5-0041-4102-bc3e-71bab6f55e7e.jpg

Lomiko Metals Inc. has been keenly watching the lithium-ion battery market in anticipation of identifying an opportunity to participate in the supply of materials for electric vehicles with its La Loutre graphite project located in Quebec, Canada.  Lomiko is focused on advancing the La Loutre graphite property and is looking to deliver an NI 43-101 graphite resource based on the success of its recently completed drilling campaign at the Refractory Zone.  This will add to the previously announced 43-101 graphite resource at the adjacent Graphene-Battery zone announced March, 2016.

A. Paul Gill, CEO states, “Lomiko believes that it is in an ideal position to participate in the burgeoning Electric Vehicle market, with the potential to become a North American supplier of graphite materials, a market currently dominated by foreign supply from China. Graphite is a major and critical material in the manufacture of lithium-ion and other batteries, specifically battery anodes”.

  • According to Benchmark Minerals, graphite anode demand is set to increase from 194,160 tonnes in 2017 to 1,080,360 tonnes by 2023 and 1,747,800 tonnes by 2028. [Source: INN Graphite Investing News]
    On February 4, 2019, Simon Moores of Benchmark Mineral Intelligence raised supply and demand concerns in a submission to the US Senate which was echoed by Energy and Natural Resource Committee Chair Senator Lisa Murkowski in a February 5, 2019 News Release: “In contrast to the energy sector, our nation is headed in the wrong direction on mineral imports. This is our Achilles’ heel that serves to empower and enrich other nations, while costing us jobs and international competitiveness,” Murkowski said. Lomiko brought this crucial opportunity to the attention of shareholders in a February 8, 2019.
  • Recent announcements and cooperation agreements on electric vehicle and self-driving cars between Ford and Volkswagen indicates automakers are taking action to put millions of electric vehicles on the road.  Raw material demand for graphite, lithium and nickel sourced from North American is likely to increase as a result. Ford said its battery electric vehicle rollout will start in 2020 with a performance utility, and it plans to launch 16 battery electric vehicles by 2022.
  • In other positive developments, Quebec Premier Francois Legault reiterated his commitment to make the Province the ‘Green Battery’ of North America through investments in electric buses and trams while British Columbia Premier John Horgan aims to eliminate all gas-powered cars by 2040.
     
    For more information on Lomiko Metals, review the website at www.lomiko.com, contact A. Paul Gill at 604-729-5312 or email: [email protected].

LOMIKO Hub on Agoracom

FULL DISCLOSURE: LOMIKO Metals is an advertising client of AGORA Internet Relations Corp.

GGX Gold: Former Lead Financial Officer of The World Bank Explains Central Banks Return to Gold $GGX.ca $NNZ.ca $GTT.ca $AOT.ca $MTB.ca

Posted by AGORACOM at 1:40 PM on Monday, July 22nd, 2019

SPONSOR: GGX’s Gold Drop property, situated in one of the most prolific gold-copper mining camps of North America, the Greenwood-Republic mining camp. The current 2019 drill program is following up on the 2018 drilling which intercepted high grade gold-silver results (129 g/t gold and 1,154 g/t silver over 7.28 meter) from the near surface COD vein which is projected to be 1.5 kms in length. Click here for more information

http://ggxgold.com/wp-content/uploads/2019/04/GGX-Logo-TSXV.png
Central Banks Return to Gold
  • Central banks bought more gold in 2018 than at any time since the early 1970s
  • Bullion holdings rose by 651.5 tons last year, the most since 1971

In the 1990s, gold was an unloved asset among central banks. Reserve managers lent or sold their gold, particularly in Europe, and the gold price fell to a low of US$250/oz. Years of persistent selling triggered the Central Bank Gold Agreement of 1999, under which signatories agreed to limit collective sales to 400 tonnes per annum, put a cap on gold leasing and take a disciplined approach to gold futures and options. 

The Agreement delivered two clear benefits: it helped to stabilise the gold price and increased transparency around central bank gold sales. Today, however, sentiment towards gold has been transformed and gold has regained its status as a valuable and highly regarded reserve asset.

In 2018 alone, central banks bought 651 tonnes of gold, up 74% compared to 2017 and the highest level since 1971.

Key Changes

A glance back over the past 20 years highlights some of the key changes in central bank behaviour. 

First, central banks have rapidly and consistently added to their foreign exchange reserves since the Asian crisis of 1998. Reserves are a crucial element in a country’s armoury, providing protection against both domestic and external shocks and acting as a show of confidence to the outside world. Emerging market economies led the charge in this respect, sending worldwide foreign exchange reserves from around US$3 trillion (tn) in 2000 to approximately US$13tn in 2014. Purchases have plateaued over the past five years but still stand at some US$13tn today.

The dollar is the most widely held reserve asset but, according to International Monetary Fund statistics, gold comes third, accounting for 11% of global reserves. Having been net sellers until 2000, central banks have been net buyers ever since. In 2018 alone, central banks bought 651 tonnes of gold, up 74% compared to 2017 and the highest level since 1971. Over the past decade, central banks have purchased more than 4,300 tonnes of gold, taking their total holdings to around 34,000 tonnes today. The trend has continued in 2019, with net purchases reaching 90 tonnes before the end of the first quarter.
Notably too, central bank buying has been geographically diverse. Russia has been the most committed purchaser of gold – acquiring almost 275 tonnes in 2018, the largest amount ever purchased in a single year. China has been consistently adding to its reserves as well, but many other emerging market countries have been accumulating gold over the past year and more, including Hungary, Poland, Egypt, Kazakhstan and India.

The Drivers

What is the rationale behind this renewed interest in gold? First, heightened uncertainty about the global economic and geo-political outlook and second, gold’s intrinsic value as a reserve asset.

Ten years after the Global Financial Crisis, the macro-economic outlook remains fragile and hard to read. In April, the IMF outlook highlighted weakening GDP growth, with risks skewed to the downside. As IMF Chief Economist Gita Gopinath explained, the global economy is at “a delicate moment”. Advanced economies are predicted to grow by just 1.8% in 2019 and 1.7% in 2020, while growth in the Euro area is expected to be even lower, at 1.6% and 1.5% respectively. The emerging market growth trajectory is more solid (4.4% in 2019 and 4.8% in 2020) but risks remain tilted downwards.
Trade tensions are a major unknown. They have already had a negative impact on growth and if the US and China do not reach a genuine truce, the global outlook may worsen further. Fears of retaliation and escalation may hit business investment, supply chains may be disrupted, and productivity may slow across the world stage. The Euro area faces specific challenges too. Business confidence is low, especially in Germany due to the introduction of new fuel emission standards in the auto industry. Fiscal policy is affecting Italian sovereign and commercial bank spreads. And, of course, uncertainty about Brexit persists, particularly as the exit date has now been postponed to October 2019.

Furthermore, global geo-political risks have not abated and may have a negative impact on economic activity. Idiosyncratic risks are increasing too, such as the rise of populist governments in Latin America and across Europe.

What is the rationale behind this renewed interest in gold? First, heightened uncertainty about the global economic and geo-political outlook and second, gold’s intrinsic value as a reserve asset.

Gold Advantages

All these uncertainties accentuate negative market sentiment and drive central bank investors to reallocate their portfolios away from risky assets to safe haven assets.

This is where gold comes into its own, as it fulfils central banks’ three core objectives: safety, liquidity and return.

Gold is well known as a safe haven asset. It carries no credit risk, has little or no correlation with other assets and the price generally increases in times of stress. As such, it offers valuable protection in times of crisis. 

Gold is highly liquid too. It can easily be traded in global market centres, such as London and New York. It can be used in swap transactions to raise liquidity when needed and it can be actively managed by reserve managers.

Gold can also enhance the risk/return profile of a central bank portfolio. Its lack of correlation to other major reserve assets makes it an effective portfolio diversifier and, over the long term, it delivers higher returns than many other assets. 

Explore findings from the World Gold Council’s 2019 Central Bank Gold Reserves Survey

SOURCE: https://www.gold.org/goldhub/research/gold-investor/central-banks-return-to-gold

American Creek Resources $AMK.ca: Eric Sprott Discusses Goldstorm Drilling Potential at AMK’s Treaty Creek $SEA.ca $SA $SKE.ca $TUD.ca $PVG.ca $MRO.ca $NGT.ca $SPMT.ca $GTT.ca $III.ca $GGI.ca $SII.ca

Posted by AGORACOM at 1:10 PM on Monday, July 22nd, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/562696/hub/HubLogoLarge2_copy.jpg
  • AMK holds a 20% Carried Interest in Treaty Creek, including Goldstorm where Tudor is currently drilling
  • The Goldstorm zone at Treaty Creek has the potential to be a world class open pit gold deposit with lower costs and far better logistics than Seabridges’ adjacent KSM
  • Assay results for Goldstorm anticipated shortly

With Eric Sprott’s latest $3,000,000 investment announced on Friday he has now personally invested $4.5 million into the Treaty Creek Joint Venture through its operator and 60% owner Tudor Gold.  In a podcast (also on Friday) Eric enthusiastically described the potential of the Treaty Creek project when he made statements like:

“It’s drilling a monster play just like the GT Gold play” “The last hole they announced, which was last year, was 563 meters of 1.08 gold”

“It’s in the perfect logistical place to develop it.  The market cap of the company (Tudor) is like under $50 million and yet what we’re shooting for is to define a 10 or 20-million-ounce discovery, so you’re paying nothing for this discovery.”

“So that’s the sort of play that I like where man, if the price of gold goes to $1,700 or $2,000 these plays will look so economically viable and the stock will go up so much, and the analogy I use is Seabridge back in 2000.  I remember buying it at a dollar…and Seabridge went from $1 to $35 dollars!  That is what we are looking for – a dollar to $35 dollars, set you up for life!”

American Creek Resources has a fully carried 20% interest (1/3 of Tudors 60% interest) in the Treaty Creek Joint Venture and has a “free ride” with no associated exploration/development costs until such time as a production notice is given. This puts American Creek shareholders in an extremely favorable leveraged position, especially considering the other exceptional properties it owns including two more in BC’s Golden Triangle.  American Creek is presently valued at, and is trading at less than 1/3 of Tudor’s present value (Treaty Creek being Tudor’s focus and flagship property), offering an even more leveraged opportunity at the moment. 

The Goldstorm zone at Treaty Creek has the potential to be a world class open pit gold deposit with lower costs and far better logistics than Seabridges’ adjacent KSM.  According to Sprott, Seabridge set a lot of people up for life and the opportunity for something similar by “paying nothing for the discovery” is right here, right now.

Click the link below for the Sprott podcast.  Tudor/Treaty Creek are discussed beginning at about the 10:07 mark….but we suggest you listen to the whole thing as Eric describes the present gold/silver market in general.

For details about the Treaty Creek JV please visit our website here:  https://americancreek.com/index.php/projects/treaty-creek/home 

American Creek is a Canadian junior mineral exploration company with a strong portfolio of gold and silver properties in British Columbia. Three of those properties are located in the prolific “Golden Triangle”; the Treaty Creek and Electrum joint venture projects with Tudor Gold/Walter Storm as well as the 100% owned past producing Dunwell Mine.

The Corporation also holds the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King properties located in other prospective areas of the province.

For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com  

Applied Biosciences $APPB: U.S. CBD Market to Grow 700% Through 2019 $WMD.ca $CGRW $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca

Posted by AGORACOM at 9:00 PM on Saturday, July 20th, 2019

SPONSOR: Applied Biosciences Corp. is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics and biopharmaceuticals, as well as state-of-the-art testing and analytics.  As a leading company in the CBD, Pet and Health and Wellness space, the company is currently shipping to the majority of US states as well as to 5 International countries. Click Here for More Info

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png
APPB : OTC
  • Brightfield Group 2019 U.S. CBD Market Report
  • Shifts across the U.S. CBD industry signal a seven-fold increase in the market
  • Bulk of growth coming from CVS, Walgreens, and Kroger entering the market and providing availability to consumers
  • 1.0% of CBD companies were in the top tier (with sales of $40+ million or being sold in greater than 1000 stores) while 92.9% of companies were in the low tier (with sales of <$1 million or being sold in 0-100 stores)

In their recent report, Brightfield Group, a leading market and consumer intelligence firm for the legal CBD and cannabis industries, uncovered numerous shifts across the U.S. CBD industry, signaling a seven-fold increase in the market. With hemp-derived CBD gaining in popularity – in line with health, wellness, and anti-pharma trends – and product availability and variety increasing, the market is on track to grow to $23.7 billion through 2023.

“The CBD market has been growing rapidly, but we will see unprecedented growth in 2019,” Brightfield Managing Director, Bethany Gomez, explains. “The bulk of this growth is coming from large retailers like CVS, Walgreens, and Kroger entering the market and providing that availability to consumers.”


Key highlights from the report:

  • Though they entered the market only this year, mass retail chains will eclipse all other channels in 2019, hosting 57% of sales this year
  • Although tinctures still dominate the market, driving 25% of sales, they are losing their lead as more mainstream consumer-friendly products surge
  • Topicals (17% of market) and skincare & beauty products (8%) have gained tremendous traction as mass retailers have signed on to carry these products first, since they are considered the safest bet under the current regulatory regime.
  • Natural food and smoke shop CBD revenues continue to grow and thrive – with increased uptake across the country and some level of saturation now that vendors feel more secure and confident carrying product. Notably, though the CBD market is no longer dominated by cannabis users, dispensaries and recreational shops have also seen an uptick in CBD-oriented traffic
  • 1.0% of CBD companies were in the top tier (with sales of $40+ million or being sold in greater than 1000 stores) while 92.9% of companies were in the low tier (with sales of <$1 million or being sold in 0-100 stores)

About Brightfield: Brightfield Group is a predictive market and consumer intelligence firm focused on the legal CBD and Cannabis industries. Their analytic solutions leverage data from millions of sources, enabling customers to get the most holistic view possible while drilling down into the fine details. They provide comprehensive, up-to-date, and actionable market and consumer insights that transform the best of research and technology into long-term business growth.
SOURCE: https://www.brightfieldgroup.com/press-releases/cbd-market-growth-2019

$LMR.ca Jason Gregg Joins Lomiko Board of Advisors $DNI.ca $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 11:17 AM on Friday, July 19th, 2019
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564363/hub/lomikoLogo300x100_copy.gif
LMR – TSX:V
  • Mr. Jason Gregg has joined the Lomiko Board of Advisors.
  • Mr. Gregg is a seasoned mining professional with a broad range of experience in leading Human Resources for mining projects in a variety of jurisdictions

Vancouver, B.C., July 19, 2019 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, LMRMF, FSE: DH8C, (ISIN: CA54163Q1028) (WKN: A0Q9W7) (LEI: 529900GJP51V4HR9MN94) is pleased to report that Mr. Jason Gregg has joined the Lomiko Board of Advisors.

“Mr. Gregg is a seasoned mining professional with a broad range of experience in leading Human Resources for mining projects in a variety of jurisdictions,” stated Mr. A. Paul Gill, CEO of Lomiko Metals.

Jason Gregg was most recently Executive Vice President, Human Resources for Alio Gold.   Mr. Gregg has more than 20 years of experience as a Human Resources professional. He holds a BBA (1995) and an MBA (2000) from Simon Fraser University. Before Alio Gold, he was Vice President of HR, Safety and Environment for Newmarket Gold. Before joining Newmarket, he provided HR consulting services to various mining organizations as well as other industries including forestry and technology. Prior to developing his consulting practice, he worked as a Human Resources executive in the mining industry with Farallon Mining and Nyrstar. Mr. Gregg has also held senior level human resource roles with HDI, International Forest Products, Canadian Forest Products, and Teck.

For more information on Lomiko Metals, review the website at www.lomiko.com, contact A. Paul Gill at 604-729-5312 or email: [email protected].

On Behalf of the Board,

“A. Paul Gill”

Chief Executive Officer

We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Attachment

A. Paul Gill
Lomiko Metals Inc. (TSX-V: LMR)
6047295312
[email protected]